Venturi Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Venturi Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-544	Closed	-$71.9K	–	1163
2024 Q4	$71.9K	Hold	544	–	–	﹤0.01%	895
2024 Q3	$79.2K	Hold	544	–	–	﹤0.01%	629
2024 Q2	$74.7K	Hold	544	–	–	﹤0.01%	563
2024 Q1	$74.7K	Hold	544	–	–	﹤0.01%	449
2023 Q4	$73.9K	Hold	544	–	–	0.01%	448
2023 Q3	$66.5K	Sell	544 -26	-5%	-$3.31K	0.01%	439
2023 Q2	$72.4K	Sell	570 -2	-0.3%	-$260	0.01%	398
2023 Q1	$73.9K	Buy	+572	New	+$74.9K	0.01%	435
2020 Q1	–	Sell	-1,704	Closed	-$205K	–	233
2019 Q4	$205K	Sell	1,704 -384	-18%	-$42.8K	0.02%	228
2019 Q3	$208K	Sell	2,088 -3,617	-63%	-$379K	0.03%	219
2019 Q2	$622K	Buy	+5,705	New	+$607K	0.08%	131

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Venturi Wealth Management's IBB Position: Q1 2025 in Review

Venturi Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 544 shares — an estimated $71.9K sold.

Venturi Wealth Management first reported a position in IBB in Q2 2019 and held it in 11 quarters. The position peaked at $622K in Q2 2019. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

Venturi Wealth Management reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
Venturi Wealth Management sold 544 iShares Biotechnology ETF shares in Q1 2025, an estimated $71.9K.
Venturi Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2019 and held it in 11 quarters.
Venturi Wealth Management's iShares Biotechnology ETF position peaked at $622K in Q2 2019.
831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Venturi Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.